Tabla de Contenidos: “…Una necesidad formativa para la mejora de las habilidades sociales en el músico / Ana Mercedes Vernia Carrasco, Josep Gustems Carnicer, Caterina Calderón Garrido -- BalletVale+: danza clásica y música para la rehabililtación de la parálisis cerebral infantil / Esther Montes Roselló, José Jaime Hidalgo de la Torre -- Acercamiento al Parkinson desde la danza terapéutica / Alba Palacios Carús, Cristina Gómez-Llusá García, Rosa M. …”
Accés lliure a "Apuntes para reescribir la historia: Marina Lie Goubonina (Noreg). Ballet y franquismo" de Ester Vendrell

Tabla de Contenidos: “…5.4 Assessing the usability of AR interfaces for path planning -- 5.4.1 Usability evaluation -- 5.5 Conclusions -- References -- Part 3: Crafting the future: System design and applications -- Chapter 6: Unveiling the future of medical imaging: Scan to VR pipeline for visualization -- 6.1 Introduction -- 6.2 Case study -- 6.3 Methodology -- 6.4 Results -- 6.5 Discussion -- 6.6 Summary and conclusion -- Acknowledgements -- References -- Chapter 7: Accelerating rehabilitation through AR/VR solutions -- 7.1 Introduction -- 7.1.1 Brief explanation of the state of the art of VR/AR systems -- 7.2 Search strategy -- 7.3 Existing AR/VR technologies for physical rehabilitation -- 7.4 AR/VR technology as healthcare treatment options -- 7.4.1 Upper limb -- 7.4.2 Lower limb -- 7.4.3 Parkinson's Disease -- 7.4.4 Stroke -- 7.4.5 Sclerosis -- 7.4.6 Pain management -- 7.5 State of art review (top 5 articles) -- 7.6 Design and development approaches for Physical Rehabilitation -- 7.6.1 Traditional research and development of AR/VR devices -- 7.6.1.1 Patient side -- 7.6.1.2 Physician/physiotherapist -- 7.6.1.3 Software -- 7.6.1.4 Limitations of AR/VR usability -- 7.6.2 FDA regulations for AR/VR product development -- 7.7 Discussion -- 7.7.1 Application and benefits -- 7.7.1.1 Mental health and concerned disorders -- 7.7.1.2 Surgical limitations and pediatric diagnosis -- 7.7.2 Emerging risks -- 7.7.3 Design standard requirements -- 7.7.4 Future research directions -- 7.8 Conclusion -- Acknowledgements -- References -- Chapter 8: Overcoming phobias: Harnessing the power of immersive virtual reality therapy -- 8.1 Introduction -- 8.1.1 Background and driving forces -- 8.2 Various types of phobias -- 8.3 Available treatments for phobias -- 8.4 Virtual reality in the treatment of phobias -- 8.5 Virtual reality systems…”

Tabla de Contenidos: “…Ellingrod -- Chapter 53: Alzheimer Disease -- Chapter 54: Epilepsy and Status Epilepticus -- Chapter 55: Headache: Migraine and Tension-Type -- Chapter 56: Pain Management -- Chapter 57: Parkinson Disease -- SECTION 10: NUTRITION SUPPORT Edited by Cecily V. …”

Tabla de Contenidos: “…Skodda, ON THE HARMONIC-TO-NOISE RATIO AS A CUE FOR AUTOMATIC CLASSIFICATION OF PARKINSON'S DISEASE -- R. Fraile, K. Neumann, J.M. …”

Tabla de Contenidos: “…Skodda, ON THE HARMONIC-TO-NOISE RATIO AS A CUE FOR AUTOMATIC CLASSIFICATION OF PARKINSON'S DISEASE -- R. Fraile, K. Neumann, J.M. …”

Tabla de Contenidos: “…Resumen -- Ejercicios de repaso y autoevaluación -- Capítulo 4 Parkinson -- 1. Introducción -- 2. Síntomas -- 3. Resumen -- Ejercicios de repaso y autoevaluación -- Capítulo 5 Alzheimer -- 1. …”

Tabla de Contenidos: “…26.Rehabilitation of Persons with Parkinson's Disease and Other Movement Disorders / Donna Moxley Scarborough -- 27.Rehabilitation of Spinal Cord Injury / Monifa Brooks -- 28.Adult Motor Neuron Disease / Gregory T. …”
Enlace del recurso

Tabla de Contenidos: “…Tecnologías para el estudio de la variabilidad del genoma -- Técnicas de bajo rendimiento -- Técnicas de rendimiento medio -- Técnicas de alto rendimiento -- Correlación genotipo-fenotipo -- Selección de casos y controles y estimación de potencia -- Selección de las variantes génicas -- Estrategias de análisis de datos -- Limitaciones de los estudios de asociación genética -- Estudios funcionales y determinación del efecto fenotípico de la variación génica -- De la asociación estadística a la variante causal -- Modelos experimentales para las validaciones funcionales -- Genética humana, descubrimiento de biomarcadores y nuevas dianas terapéuticas: casos de éxito -- Conclusiones -- Bibliografía -- Avances en neuroendocrinología clínica: papel de los neuropéptidos y su regulación proteolítica -- Historia -- Neuropéptidos -- Coexistencia de neurotransmisores en una misma neurona -- Funcionalidad de neuropéptidos y neuropeptidasas -- Técnicas utilizadas en neuroendocrinología -- Arilamidas -- Neuroendocrinología -- Interacción central y periférica en condiciones fisiológicas y patológicas -- Neuroendocrinología de la enfermedad de Parkinson -- Neuroendocrinología de las enfermedades cardiovasculares -- Neuroendocrinología de la obesidad -- Papel del hipotálamo en la regulación de la ingesta de alimento -- Conclusión -- Bibliografía -- Detección del cáncer colorrectal desde el laboratorio clínico mediante procedimientos no invasivos -- Introducción -- Marcadores tumorales serológicos clásicos -- Estrategias para optimizar el uso de los marcadores tumorales tradicionales -- Marcadores serológicos de proliferación, inflamación y angiogénesis -- Piruvato quinasa tumoral M2 plasmática (M2-PK) -- Citoquinas inflamatorias (IL-6) -- VEGF -- Marcadores fecales -- Sangre oculta en heces (cribado poblacional) -- Piruvato quinasa tumoral M2 fecal -- ADN fecal…”

Tabla de Contenidos: “…Case 001-Surgical Care -- Case 002-Hypertension Case # 1 -- Case 003-Hypertension Case # 2 -- Case 004-Hypertension Case # 3 -- Case 005-Hypertension Case # 4 -- Case 006-Hypertension Case # 5 -- Case 007-Dyslipidemia Case # 1 -- Case 008-Dyslipidemia Case # 2 -- Case 009-Stable Ischemic Heart Disease -- Case 010-Acute Coronary Syndromes -- Case 011-Cardiovascular Respiratory Decompensation -- Case 012-Chronic Heart Failure Case # 1 -- Case 013-Chronic Heart Failure Case # 2 -- Case 014-Venous Thromboembolism-Pulmonary Embolism Case # 1 -- Case 015-Venous Thromboembolism-Pulmonary Embolism Case # 2 -- Case 016-Stroke -- Case 017-Arrhythmias -- Case 018-Cardiac Arrest, Resuscitation -- Case 019-Acne and Pediatric Dermatology Disorders -- Case 020-Psoriasis -- Case 021-Atopic Dermatitis -- Case 022-Miscellaneous Dermatology -- Case 023-Peptic Ulcer Disease, GERD Case # 1 -- Case 024-Peptic Ulcer Disease, GERD Case # 2 -- Case 025-Irritable Bowel Syndrome -- Case 026-Diarrhea -- Case 027-Constipation -- Case 028-Crohn Disease -- Case 029-Anemia -- Case 030-CNS Infections -- Case 031-Lower Respiratory Tract Infection -- Case 032-Upper Respiratory Tract Infection -- Case 033-Skin and Soft-Tissue Infections; Fungal (Multiple Patient Case) -- Case 034-Infective Endocarditis -- Case 035-Gastrointestinal Infections -- Case 036-Intra-Abdominal Infections -- Case 037-Urinary Tract Infection -- Case 038-Skin and Soft Tissue Infection (Bacterial), Bone and Joint Infections -- Case 039-Miscellaneous Bacterial Infections -- Case 040-Sexually Transmitted Infections -- Case 041-Sepsis and Septic Shock -- Case 042-Fungal Infections Case # 1 -- Case 043-Fungal Infections Case # 2 -- Case 044-Viral Infections -- Case 045-Parasitic Infections -- Case 046-Infectious Endocarditis -- Case 047-Viral Hepatitis, Hepatitis Vaccination -- Case 048-Influenza and Influenza Vaccination (Multiple Patient Case) -- Case 049-Foot and Nail Fungal Infection -- Case 050-Vaccines Case # 1 -- Case 051-Vaccines Case # 2 -- Case 052-Travel Health (Multiple Patient Case) -- Case 053-Human Immunodeficiency Virus Infection -- Case 054-Systemic Lupus Erythematosus -- Case 055-Solid Organ Transplantation -- Case 056-Erectile Dysfunction -- Case 057-Benign Prostatic Hyperplasia -- Case 058-Attention Deficit Hyperactivity Disorder -- Case 059-Substance Use Disorders (Opioids) -- Case 060-Substance-Related Disorders (Alcohol, Nicotine) -- Case 061-Schizophrenia -- Case 062-Depression Case # 1 -- Case 063-Depression Case # 2 -- Case 064-Panic Disorder -- Case 065-Bipolar Disorder -- Case 066-Anxiety Disorders Case # 1 -- Case 067-Anxiety Disorders Case # 2 -- Case 068-Sleep-Wake Disorders -- Case 069-Diabetes Mellitus (Type 2) Case # 1 -- Case 070-Diabetes Mellitus (Type 2) Case # 2 -- Case 071-Diabetes Mellitus (Type 2) Case # 3 -- Case 072-Thyroid Disorders -- Case 073-Obesity -- Case 074-Migraine Headache -- Case 075-Critical Care Pain, Agitation, Delirium -- Case 076-Alzheimer Disease -- Case 077-Multiple Sclerosis -- Case 078-Epilepsy Case # 1 -- Case 079-Epilepsy Case # 2 -- Case 080-Parkinson Disease -- Case 081-Pain Management Case # 1 -- Case 082-Pain Management Case # 2 -- Case 083-Pain Management Case # 3 -- Case 084-Brain Cancer -- Case 085-Breast Cancer -- Case 086-Lung Cancer -- Case 087-Colorectal Cancer -- Case 088-Prostate Cancer -- Case 089-Hodgkin Lymphoma -- Case 090-Lymphoma -- Case 091-Acute Myeloid Leukemia -- Case 092-Chronic Lymphocytic Leukemia -- Case 093-Multiple Myeloma -- Case 094-Myelodysplastic Syndrome -- Case 095-Renal Cell Cancer -- Case 096-Melanoma -- Case 097-Ovarian Cancer -- Case 098-Chemotherapy-Induced Emesis -- Case 099-Cancer Pain -- Case 100-Stem Cell Transplant -- Case 101-Idiopathic Thrombocytopenic Purpura, Thrombotic Thrombocytopenic Purpura -- Case 102-Glaucoma -- Case 103-Bacterial Conjunctivitis -- Case 104-Allergic Conjunctivitis -- Case 105-Asthma Case # 1 -- Case 106-Asthma Case # 2 -- Case 107-Allergic Rhinitis Case # 1 -- Case 108-Allergic Rhinitis Case # 2 -- Case 109-Chronic Obstructive Pulmonary Disease -- Case 110-Osteoarthritis -- Case 111-Rheumatoid Arthritis -- Case 112-Osteoporosis -- Case 113-Gout -- Case 114-Urinary Disorders - Male -- Case 115-Urinary Disorders - Female -- Case 116-Menopause Care -- Case 117-Menstruation-Related Disorders -- Case 118-Contraception -- Case 119-Obstetric Care -- Case 120-Family Medicine Case # 1 (Multiple Patient Case) -- Case 121-Family Medicine Case # 2 (Multiple Patient Case) -- Case 122-Family Medicine Case # 3 (Multiple Patient Case) -- Case 123-Family Medicine Case # 4 (Multiple Patient Case) -- Case 124-Family Medicine Case # 5 (Multiple Patient Case) -- Case 125-Family Medicine Case # 6 (Multiple Patient Case)…”

Tabla de Contenidos: “…- Clinical and Statistical Considerations when Assessing Oxygen Levels in Tumors: Illustrative Results from Clinical EPR Oximetry Studies -- Fatal Alliance of Hypoxia-/HIF-1α-driven Microenvironmental Traits Promoting Cancer Progression -- Quantification of Tumor Oxygenation based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference Region -- Pathways of Oxygen Diffusion in Cells and Tissues: Hydrophobic channeling via networked lipids -- Part III Muscle Oxygenation and Sports Medicine -- Effect of Exercise Duration on Post-exercise Persistence of Oxyhemoglobin Changes in the Premotor Cortex: A Near-infrared Spectroscopy Study in Moderate-intensity Cycling Exercise -- Relationship Between Muscle Oxygen Saturation and Exercise Load in Patients with Malignant Hematopoietic Disease -- Comparison of the Effects of Continuous and Intermittent Exercise on Cerebral Oxygenation and Cognitive Function -- Relationship between Exercise Capacity and Muscle O2Hb saturation in Patients before Hematopoietic Stem-Cell Transplantation -- Differences in Muscle O2 Dynamics During Treadmill Exercise Between Aerobic Capacity-matched Overweight and Normal-weight Adults -- Cerebral Oxygenation Dynamics of the Prefrontal Cortex and Motor-Related Area During Cardiopulmonary Exercise Test: A Near-infrared Spectroscopy Study -- Reduced Optical Path Length in the Vastus Lateralis during Ramp Cycling Exercise -- Improvements in Skeletal Muscle can be Detected using Broadband NIRS in First-Time Marathon Runners -- Comparison of Two NIRS Tissue Oximeters (Moxy and Nimo) for Non-invasive Assessment of Muscle Oxygenation and Perfusion -- Part IV Cell Metabolism and Tissue Oxygenation -- Effects of Pulsed Magnetic Field on the Hemolysis of Erythrocytes Exposed to Oxidative Stress -- Role of Microtubule-associated Factors in HIF1α Nuclear Translocation -- Extracellular Acidosis Regulates the Expression of Inflammatory Mediators in Rat Epithelial Cells -- Part V Methodology of O2 Measurements -- Reducing False Alarm Rates in Neonatal Intensive Care: A New Machine Learning Approach -- Development of an IoT-based Monitoring System for Healthcare: A Preliminary Study -- Developing a Model to Simulate the Effect of Hypothermia on Cerebral Blood Flow and Metabolism -- Validation and Comparison of Monte Carlo and Finite Element Method in Forward Modeling for Near Infrared Optical Tomography -- Development of a Cuff-less Blood Pressure Monitoring System and its Application -- Usefulness of a New Device to Monitor Cerebral Blood Oxygenation using NIRS during Cardiopulmonary Resuscitation in Patients with Cardiac Arrest: A Pilot Study -- Application of Peripheral Near Infrared Spectroscopy to Assess Risk Factors in Patient with Coronary Artery Disease: Part 1 -- Broadband NIRS Cerebral Evaluation of the Hemodynamic and Oxidative State of Cytochrome-c-oxidase Responses to +Gz Acceleration in Healthy Volunteers -- Time-resolved NIROT ‘Pioneer’ System for Imaging Oxygenation of the Preterm Brain: Preliminary Results -- Application of Peripheral Near Infrared Spectroscopy to Assess Risk Factors in Patient with Coronary Artery Disease: Part 2 -- Optimization of Band Selection in Multispectral and Narrow-Band Imaging: An Analytical Approach -- Fabrication and Optical Characterization of Gelatin-Based Phantoms for Tissue Oximetry -- Two-Photon Autofluorescence Imaging of Fixed Tissues: Feasibility and Potential Values for Biomedical Applications -- Part VI Special Topics -- Acute Anemia Induces Erythropoiesis in Rat Organ Surface Primo-Vascular Tissue -- Analysis and Differential Expression of Primo Genes using RNA-Seq and qRT-PCR Experiments -- Acupuncture Inhibits the Increase in Alpha-synuclein in Substantia nigra in an MPTP- induced Parkinsonism Mouse Model -- On the Biomarkers of Alzheimer’s Disease -- Effective Murine Model Induction for Niche Study in Immune Cells against Leukemia -- Index…”

Tabla de Contenidos: “…Caso 3.7: Extrañamente callado Caso 3.8: Cambio en el posparto Caso 3.9: Ansiedad 4 Trastornos depresivos Introducción Caso 4.1: Temperamental e irritable Caso 4.2: Tristeza posparto Caso 4.3: Duelo y depresión Caso 4.4: Perdió el interés por la vida Caso 4.5: Desesperación Caso 4.6: Años abatida Caso 4.7: Cambios de humor Caso 4.8: Estrés, drogas e infelicidad Caso 4.9: Luchando con la enfermedad de Parkinson Caso 4.10: Cambios de humor situacionales Caso 4.11: De mal en peor Caso 4.12: Insomnio y síntomas físicos 5 Trastornos de ansiedad Introducción Caso 5.1: Miedos y preocupaciones Caso 5.2: Pánico Caso 5.3: Timidez de adolescente Caso 5.4: Miedo a volar Caso 5.5: Siempre tensa Caso 5.6: Ansiedad y cirrosis 6 Trastornos obsesivo-compulsivo y trastornos relacionados Introducción Caso 6.1: Depresión Caso 6.2: Gérmenes Caso 6.3: Preocupación por el aspecto Caso 6.4: Depresión y ansiedad Caso 6.5: Pelo arrancado 7 Trastornos relacionados con traumas y factores de estrés Introducción Caso 7.1: Conductas peligrosas Caso 7.2: Dos reacciones al trauma Caso 7.3: Accidente de coche Caso 7.4: Poco aguante Caso 7.5: Estresado Caso 7.6: Cáncer de pulmón Caso 7.7: Sobredosis 8 Trastornos disociativos Introducción Caso 8.1: Triste y sola Caso 8.2: Sensación de estar ido Caso 8.3: Disociaciones 9 Trastornos de síntomas somáticos y trastornos relacionados Introducción Caso 9.1: Dolor y depresión Caso 9.2: Quejas somáticas Caso 9.3: Enfermedad de Lyme crónica Caso 9.4: Crisis epilépticas Caso 9.5: Dolor abdominal Caso 9.6: Sin aliento 10 Trastornos de la conducta alimentaria y la ingesta de alimentos Introducción Caso 10.1: Dolor de estómago Caso 10.2: Rezagada en la curva de crecimiento Caso 10.3: Dolores de cabeza y fatiga Caso 10.5: Aumento de peso 11 Trastornos de la excreción Introducción Caso 11.1: Rabietas y síntomas somáticos 12 Trastornos del sueño-vigilia Introducción Caso 12.1: Problemas para dormir de un tirón Caso 12.2: Ansiedad y sueño Caso 12.3: Somnolencia Caso 12.4: Picores y cosquilleos 13 Disfunciones sexuales Introducción Caso 13.1: Disfunción sexual Caso 13.2: Problemas sexuales 14 Disforia de género Introducción Caso 14.1: Reasignación de género 15 Trastornos disruptivos, del control de los impulsos y de la conducta Introducción Caso 15.1: No conoce las normas Caso 15.2: Convivencia imposible 16 Trastornos relacionados con sustancias y trastornos adictivos Introducción Caso 16.1: Un alcohólico «típico» Caso 16.2: Abstinencia de alcohol Caso 16.3: Adicción Caso 16.4: Dolor de rodilla Caso 16.5: Espiral descendente Caso 16.6: Estrés y abuso de sustancias Caso 16.7: Juego 17 Trastornos neurocognitivos Introducción Caso 17.1: Disforia Caso 17.2: Agitado y confuso Caso 17.3: Deprimido y retraído Caso 17.4: Desarreglada y exhausta Caso 17.5: Rígido y olvidadizo Caso 17.6: Paranoia y alucinaciones Caso 17.7: Rebelde de pronto 18 Trastornos de la personalidad Introducción Caso 18.1: Conflictos de la personalidad Caso 18.2: Extrañamente aislado Caso 18.3: Preocupado y extrañamente absorto Caso 18.4: Injusticia Caso 18.5: Frágil y enojada Caso 18.6: Suicidalidad dolorosa Caso 18.7: Insatisfacción Caso 18.8: Timidez Caso 18.9: Falta de confianza en sí mismo Caso 18.10: Controlar la relación 19 Trastornos parafílicos Introducción Caso 19.1: Sadismo Caso 19.2: Problemas de relación Caso 19.3: Delitos sexuales Caso 19.4: Algunas perversiones Índice analítico…”

Tabla de Contenidos: “…-- ESSENTIAL CONCEPTS -- SUMMARY OF REACTIONS -- PROBLEMS -- 7 The Reactions of Alkynes An Introduction to Multistep Synthesis -- MEDICAL CONNECTION: Synthetic Alkynes Are Used to Treat Parkinson's Disease -- PHARMACEUTICAL CONNECTION: Why Are Drugs so Expensive? …”

Tabla de Contenidos: “…Section 1: Foundation Issues -- Chapter e1: Health Literacy and Medication Use -- Chapter e2: Cultural Competency -- Chapter e3: Medication Safety Principles and Practices -- Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics -- Chapter e5: Pharmacogenetics -- Chapter e6: Pediatrics -- Chapter e7: Geriatrics -- Chapter e8: Palliative Care -- Chapter e9: Clinical Toxicology -- Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions -- Section 2: Cardiovascular Disorders -- Chapter e11: Cardiovascular Testing -- Chapter 12: Cardiac Arrest -- Chapter 13: Hypertension -- Chapter 14: Chronic Heart Failure -- Chapter 15: Acute Decompensated Heart Failure -- Chapter 16: Stable Ischemic Heart Disease -- Chapter 17: Acute Coronary Syndromes -- Chapter 18: The Arrhythmias -- Chapter 19: Venous Thromboembolism -- Chapter 20: Stroke -- Chapter 21: Dyslipidemia -- Chapter e22: Peripheral Arterial Disease -- Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock -- Chapter 24: Hypovolemic Shock -- Chapter e25: Introduction to Pulmonary Function Testing -- Section 3: Respiratory Disorders -- Chapter 26: Asthma -- Chapter 27: Chronic Obstructive Pulmonary Disease -- Chapter 28: Pulmonary Arterial Hypertension -- Chapter 29: Cystic Fibrosis -- Chapter e30: Drug-Induced Pulmonary Diseases -- Section 4: Gastrointestinal Disorders -- Chapter e31: Evaluation of the Gastrointestinal Tract -- Chapter 32: Gastroesophageal Reflux Disease -- Chapter 33: Peptic Ulcer Disease and Related Disorders -- Chapter 34: Inflammatory Bowel Disease -- Chapter 35: Nausea and Vomiting -- Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome -- Chapter 37: Portal Hypertension and Cirrhosis -- Chapter e38: Drug-Induced Liver Disease -- Chapter 39: Pancreatitis -- Chapter 40: Viral Hepatitis -- Chapter 41: Celiac Disease -- Section 5: Renal Disorders -- Chapter e42: Evaluation of Kidney Function -- Chapter 43: Acute Kidney Injury -- Chapter 44: Chronic Kidney Disease -- Chapter 45: Hemodialysis and Peritoneal Dialysis -- Chapter 46: Drug-Induced Kidney Disease -- Chapter 47: Glomerulonephritis -- Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease -- Chapter 49: Disorders of Sodium and Water Homeostasis -- Chapter 50: Disorders of Calcium and Phosphorus Homeostasis -- Chapter 51: Disorders of Potassium and Magnesium Homeostasis -- Chapter 52: Acid-Base Disorders -- Section 6: Neurologic Disorders -- Chapter e53: Evaluation of Neurologic Illness -- Chapter 54: Alzheimer Disease -- Chapter 55: Multiple Sclerosis -- Chapter 56: Epilepsy -- Chapter 57: Status Epilepticus -- Chapter 58: Acute Management of the Brain Injury Patient -- Chapter 59: Parkinson Disease -- Chapter 60: Pain Management -- Chapter 61: Headache Disorders -- Section 7: Psychiatric Disorders -- Chapter e62: Assessment of Psychiatric Disorders -- Chapter 63: Attention Deficit/Hyperactivity Disorder -- Chapter 64: Eating Disorders -- Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens -- Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine -- Chapter 67: Schizophrenia -- Chapter 68: Major Depressive Disorder -- Chapter 69: Bipolar Disorder -- Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders.5050 Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder -- Chapter 72: Sleep-Wake Disorders -- Chapter 73: Disorders Associated with Intellectual Disabilities -- Section 8: Endocrinologic Disorders -- Chapter 74: Diabetes Mellitus -- Chapter 75: Thyroid Disorders -- Chapter 76: Adrenal Gland Disorders -- Chapter e77: Pituitary Gland Disorders -- Section 9: Gynecologic and Obstetric Disorders -- Chapter 78: Pregnancy and Lactation: Therapeutic Considerations -- Chapter 79: Contraception -- Chapter 80: Menstruation-Related Disorders -- Chapter 81: Endometriosis -- Chapter 82: Hormone Therapy in Women -- Section 10: Urologic Disorders -- Chapter 83: Erectile Dysfunction -- Chapter 84: Benign Prostatic Hyperplasia -- Chapter 85: Urinary Incontinence -- Section 11: Immunologic Disorders -- Chapter e86: Function and Evaluation of the Immune System -- Chapter 87: Systemic Lupus Erythematosus -- Chapter e88: Drug Allergy -- Chapter 89: Solid-Organ Transplantation -- Section 12: Rheumatologic Disorders -- Chapter 90: Osteoarthritis -- Chapter 91: Rheumatoid Arthritis -- Chapter 92: Osteoporosis and Osteomalacia -- Chapter 93: Gout and Hyperuricemia -- Section 13: Ophthalmic and Otolaryngological Disorders -- Chapter 94: Glaucoma -- Chapter 95: Allergic Rhinitis -- Section 14: Dermatologic Disorders -- Chapter 96: Acne Vulgaris -- Chapter 97: Psoriasis -- Chapter 98: Atopic Dermatitis -- Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions -- Section 15: Hematologic Disorders -- Chapter 100: Anemias -- Chapter 101: Coagulation Disorders -- Chapter 102: Sickle Cell Disease -- Chapter e103: Drug-Induced Hematologic Disorders -- Section 16: Infectious Diseases -- Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy -- Chapter 105: Antimicrobial Regimen Selection -- Chapter 106: Central Nervous System Infections -- Chapter 107: Lower Respiratory Tract Infections -- Chapter 108: Upper Respiratory Tract Infections -- Chapter 109: Influenza -- Chapter 110: Skin and Soft-Tissue Infections -- Chapter 111: Infective Endocarditis -- Chapter 112: Tuberculosis -- Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings -- Chapter 114: Intra-Abdominal Infections -- Chapter 116: Urinary Tract Infections and Prostatitis -- Chapter e115: Parasitic Diseases -- Chapter 117: Sexually Transmitted Diseases -- Chapter 118: Bone and Joint Infections -- Chapter 119: Sepsis and Septic Shock -- Chapter 120: Superficial Fungal Infections -- Chapter 121: Invasive Fungal Infections -- Chapter 122: Infections in Immunocompromised Patients -- Chapter 123: Antimicrobial Prophylaxis in Surgery -- Chapter e124: Travel Health -- Chapter 125: Vaccines and Immunoglobulins -- Chapter 126: Human Immunodeficiency Virus Infection -- Section 17: Oncologic Disorders -- Chapter 127: Cancer Treatment and Chemotherapy -- Chapter 128: Breast Cancer -- Chapter 129: Lung Cancer -- Chapter 130: Colorectal Cancer -- Chapter 131: Prostate Cancer -- Chapter 132: Lymphomas -- Chapter 133: Ovarian Cancer -- Chapter 134: Acute Leukemias -- Chapter 135: Chronic Leukemias -- Chapter 136: Multiple Myeloma -- Chapter e137: Myelodysplastic Syndromes -- Chapter e138: Renal Cell Carcinoma -- Chapter 139: Melanoma -- Chapter 140: Hematopoietic Stem Cell Transplantation -- Section 18: Nutritional Disorders -- Chapter 141: Assessment of Nutrition Status and Nutrition Requirements -- Chapter 142: Parenteral Nutrition -- Chapter 143: Enteral Nutrition -- Chapter 144: Obesity…”

Tabla de Contenidos: “…12.2.8 Neuronale Organoide -- 12.2.9 Haut, Haar, Talg- und Schweißdrüsen -- 12.3 Biomaterialien -- 12.4 Genetische Modifikation von Organoiden -- 12.5 Zusammenfassung und Ausblick -- Literatur -- 13: Zelltypen aus menschlichen pluripotenten Zellen und deren Anwendung in Zelltherapien -- 13.1 Einleitung -- 13.2 Herzmuskelzellen (Kardiomyozyten) aus pluripotenten Stammzellen -- 13.3 Pankreatische β-Zellen aus pluripotenten Stammzellen zur Behandlung von Diabetes -- 13.4 Blutzellen aus pluripotenten Stammzellen -- 13.5 Retinales Pigmentepithel aus pluripotenten Stammzellen zur Behandlung retinaler Degenerationen -- 13.6 Dopaminerge Neuronen aus pluripotenten Stammzellen zur Behandlung von Parkinson -- 13.7 Herstellung GMP-konformer Zelltypen aus pluripotenten Stammzellen -- 13.8 Ausblick -- Literatur -- 14: Therapien zum Zellersatz mit adulten Stammzelltypen -- 14.1 Einleitung -- 14.2 Hämatopoetische Stammzellen zur Behandlung von genetischen Erkrankungen und zum Immunreset bei Autoimmunerkrankungen -- 14.3 Therapeutischer Einsatz von mesenchymalen stromalen Zellen -- 14.4 Zellersatz bei Hautverletzungen und -erkrankungen, Hornhautverletzungen und Haarersatz -- 14.5 Genetisch modifizierte Satellitenzellen der Muskeln zur Behandlung von Muskeldystrophien -- 14.6 Extrazelluläre Vesikel (Exosomen) von Stammzellen in der therapeutischen Anwendung -- 14.7 Ausblick -- Literatur -- 15: Spotlight: Ungeprüfte Stammzelltherapien -- 15.1 Einleitung -- 15.2 Ungeprüfte Stammzelltherapien - ein komplexes und internationales Problem -- 15.3 Maßnahmen: Informationen und Aufklärung -- Literatur -- 16: Gentherapie aus der Sicht eines forschenden Arzneimittelunternehmens -- 16.1 Bisherige Therapieformen (z. …”

Tabla de Contenidos: “…Industry -- cc) Rezeption US-amerikanischer Beiträge -- b) Etablierung des Themas ab 1987 -- aa) Interessenverbände -- bb) Ökonomie -- (1) Volkswirtschaftliche Dokumentation und Analyse des decline -- (2) Managementforschung -- (3) Institutionelle Investoren, Investitionsbewertung und Analystenverhalten -- (4) Übernahmen -- (5) Umfragestudien zur Managersicht, Managervergütung -- cc) Rechtswissenschaft -- (1) Der Pionier: J. Parkinsons „Corporate Power and Responsibility" -- (2) Die nachfolgende Diskussion -- (a) Übernahmen -- (b) Nicht geschäftsführende Direktoren -- (c) Institutionelle Aktionäre -- (d) Unternehmenszielbestimmung…”

Tabla de Contenidos: “…UX DESIGN: HAZLO FÁCIL PENSANDO EN EL USUARIO -- PÁGINA LEGAL -- AUTOR -- ÍNDICE -- PREFACIO -- CONTENIDO -- ORIENTACIÓN A LOS LECTORES -- AGRADECIMIENTOS -- 1- INTRODUCCIÓN -- LA INTERACCIÓN PERSONA-ORDENADOR (IPO/HCI) -- PRINCIPIOS DE INTERACCIÓN DE LICKLIDER Y CLARK -- PRINCIPIOS PARA EL DISEÑO DE SISTEMAS INTERACTIVOS DE HANSEN -- LA INTERFAZ DE USUARIO -- LA USABILIDAD -- QUÉ ES LA USABILIDAD -- USABILIDAD OBJETIVA O INHERENTE -- USABILIDAD SUBJETIVA O APARENTE -- CÓMO SE PUEDE ASEGURAR LA USABILIDAD -- INGENIERÍA DE LA USABILIDAD -- ESPECIFICACIÓN -- DISEÑO -- EVALUACIÓN -- DISEÑO CENTRADO EN EL USUARIO -- PROCESO DE DISEÑO CENTRADO EN EL USUARIO -- FASE DE DISEÑO -- FASE DE EVALUACIÓN -- 2- LEYES DE LA USABILIDAD -- GENERALIDADES -- EFECTO DE LA USABILIDAD ESTÉTICA -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- EFECTO VON RESTORFF -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- EFECTO ZEIGARNIK -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- LEY DE LOS 3 CLICS -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- LEY DE BROOKS -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- LEY DE LA COMPLEJIDAD AÑADIDA -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- LEY DE LA CONSISTENCIA -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- LEY DE EBBINGHAUS -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- LEY DE FITTS -- EXPLICACIÓN DEL CONCEPTO -- FORMULACIÓN DE LA LEY -- APLICACIÓN PRÁCTICA -- LEY DE HICK-HYMAN -- EXPLICACIÓN DEL CONCEPTO -- EXCEPCIONES -- FORMULACIÓN DE LA LEY -- APLICACIÓN PRÁCTICA -- LEY DE MILLER -- EXPLICACIÓN DEL CONCEPTO -- EVALUAR LA CARGA COGNITIVA -- APLICACIÓN PRÁCTICA -- LEY DE MOORE -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- LEY DE PARETO -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA -- EXCEPCIONES -- LEY DE PARKINSON -- EXPLICACIÓN DEL CONCEPTO -- APLICACIÓN PRÁCTICA…”

Tabla de Contenidos: “…3.5.3 Proposed Distributed Ledger-Based IoT Cloud IAM -- 3.6 Conclusion -- References -- 4 Automated TSR Using DNN Approach for Intelligent Vehicles -- 4.1 Introduction -- 4.2 Literature Survey -- 4.3 Neural Network (NN) -- 4.4 Methodology -- 4.4.1 System Architecture -- 4.4.2 Database -- 4.5 Experiments and Results -- 4.5.1 FFNN -- 4.5.2 RNN -- 4.5.3 CNN -- 4.5.4 CNN -- 4.6 Discussion -- 4.7 Conclusion -- References -- 5 Honeypot: A Trap for Attackers -- 5.1 Introduction -- 5.1.1 Research Honeypots -- 5.1.2 Production Honeypots -- 5.2 Method -- 5.2.1 Low-Interaction Honeypots -- 5.2.2 Medium-Interaction Honeypots -- 5.2.3 High-Interaction Honeypots -- 5.3 Cryptanalysis -- 5.3.1 System Architecture -- 5.3.2 Possible Attacks on Honeypot -- 5.3.3 Advantages of Honeypots -- 5.3.4 Disadvantages of Honeypots -- 5.4 Conclusions -- References -- 6 Examining Security Aspects in Industrial-Based Internet of Things -- 6.1 Introduction -- 6.2 Process Frame of IoT Before Security -- 6.2.1 Cyber Attack -- 6.2.2 Security Assessment in IoT -- 6.2.2.1 Security in Perception and Network Frame -- 6.3 Attacks and Security Assessments in IIoT -- 6.3.1 IoT Security Techniques Analysis Based on its Merits -- 6.4 Conclusion -- References -- 7 A Cooperative Navigation for Multi-Robots in Unknown Environments Using Hybrid Jaya-DE Algorithm -- 7.1 Introduction -- 7.2 Related Works -- 7.3 Problem Formulation -- 7.4 Multi-Robot Navigation Employing Hybrid Jaya-DE Algorithm -- 7.4.1 Basic Jaya Algorithm -- 7.5 Hybrid Jaya-DE -- 7.5.1 Mutation -- 7.5.2 Crossover -- 7.5.3 Selection -- 7.6 Simulation Analysis and Performance Evaluation of Jaya-DE Algorithm -- 7.7 Total Navigation Path Deviation (TNPD) -- 7.8 Average Unexplored Goal Distance (AUGD) -- 7.9 Conclusion -- References -- 8 Categorization Model for Parkinson's Disease Occurrence and Severity Prediction -- 8.1 Introduction…”

“…The clinical phenomenology of dystonia as approached in the book is interesting because, not only were the cervical, oromandibular/lingual/laryngeal, task-specific and secondary dystonias dealt with individually, but that the associated features such as parkinsonism, tremors and spasticity were also separately presented. …”

“…Several chapters are dedicated to outlining the manifestation and consequences of dysphagia in specific populations, including persons with Parkinsons disease, dystonia, chronic obstructive pulmonary disease and mixed connective tissue disease…”

“…The pathogenesis of late-onset neurological diseases such as Alzheimer’s, Parkinsonism, and ALS. Key aspects of protein misfolding. …”